Alternatively, Th2 cells can contribute to tumor immune escape through production of IL-10 and IL-4, both of which inhibit the response of Th1 cell effectors, the verification response of inflammatory cells, antigen promotion, and T cell proliferation (Thakur et al., 2012). The gene discussed is IL10; the disease is neoplasm.